.png)
From a record 170 applications, 15 companies have been selected to pitch on the mainstage at Women's Health Week USA 2026. Across two categories — Therapeutics & Medical Devices, and Consumer & Tech —these are the companies we believe represent the next wave of innovation in women's health.
They'll be pitching live at the New York Academy of Medicine on May 13 and 14, in front of investors, corporates and partners actively looking to back, buy or build with the best in the category.
Here's who made it.
Therapeutics & Medical Devices
Judges: Lily Chang (Novo Holdings), Assia Graziolo-Venier (Muse Capital)
80Beats Medical GmbH
Women's Health Focus: Reproductive Health, Maternal Health, Cardiovascular
Product: Medical Device, Diagnostic, Software
Funding Stage: Seed
Geographical Focus: North America, UK, Europe
80 Beats Medical is developing non-invasive digitalbiomarkers that provide quick and accurate assessment of cardiovascular diseaserisk in women. Their technology addresses one of the most underdiagnosedconditions in women's health, bringing diagnostic precision to a populationthat has historically been overlooked in cardiovascular research and treatment.
Aviva Bio
Women's Health Focus: Sexual Health, Menopause,Oncology
Product: Drug Development
Funding Stage: Series A
GeographicalFocus: North America
Aviva Bio is developing non-aromatizing testosterone tounlock safe, approved hormone therapy for women. Their work addresses asignificant gap in menopause care, where women have long lacked access totestosterone therapies that are both effective and safe for those withhormone-sensitive cancers or other contraindications to conventional treatment.
